Harbour Investments’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$502K Buy
6,273
+3,365
+116% +$277K 0.01% 1055
2025
Q4
$248K Buy
2,908
+231
+9% +$19K 0.01% 1179
2025
Q3
$208K Buy
2,677
+158
+6% +$12.3K ﹤0.01% 1213
2025
Q2
$197K Sell
2,519
-92
-4% -$6.86K 0.01% 1184
2025
Q1
$189K Sell
2,611
-3
-0.1% -$215 0.01% 1118
2024
Q4
$194K Sell
2,614
-140
-5% -$9.8K 0.01% 1068
2024
Q3
$182K Sell
2,754
-4
-0.1% -$291 0.01% 1050
2024
Q2
$255K Sell
2,758
-12
-0.4% -$1.06K 0.01% 853
2024
Q1
$265K Sell
2,770
-862
-24% -$72.4K 0.01% 813
2023
Q4
$277K Buy
3,632
+471
+15% +$32.8K 0.01% 731
2023
Q3
$219K Buy
3,161
+590
+23% +$47.4K 0.01% 761
2023
Q2
$243K Buy
2,571
+11
+0.4% +$956 0.01% 725
2023
Q1
$212K Sell
2,560
-4
-0.2% -$314 0.01% 750
2022
Q4
$191K Sell
2,564
-121
-5% -$9.33K 0.01% 756
2022
Q3
$255K Hold
2,685
0.02% 605
2022
Q2
$255K Buy
+2,685
New +$278K 0.02% 605
2021
Q4
$466K Sell
3,595
-3,564
-50% -$416K 0.03% 444
2021
Q3
$810K Sell
7,159
-3,865
-35% -$441K 0.03% 500
2021
Q2
$1.14M Sell
11,024
-111
-1% -$10.5K 0.04% 423
2021
Q1
$931K Buy
+11,135
New +$941K 0.03% 430

Other funds holding EW

Harbour Investments's EW Position: Q1 2026 in Review

Harbour Investments increased its Edwards Lifesciences (EW) stake by 116% in Q1 2026, buying an estimated $277K and bringing the position to 6,273 shares worth $502K. The position accounts for 0.01% of the portfolio, ranked #1055.

Harbour Investments first reported a position in EW in Q1 2021 and has held it in 20 quarters since. The position peaked at $1.14M in Q2 2021. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Harbour Investments held 6,273 shares of Edwards Lifesciences worth $502K as of Q1 2026.
  • Harbour Investments bought 3,365 Edwards Lifesciences shares in Q1 2026, an estimated $277K.
  • Edwards Lifesciences made up 0.01% of Harbour Investments's portfolio in Q1 2026, its #1055 holding.
  • Harbour Investments first reported a position in Edwards Lifesciences in Q1 2021 and has held it in 20 quarters since.
  • Harbour Investments's Edwards Lifesciences position peaked at $1.14M in Q2 2021.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.